Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracycline-induced Cardiotoxicity”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableStudy completedNCT05923242
What this trial is testing

Translating ECHOS2 Into an mHealth Platform

Who this might be right for
Childhood CancerCardiac ToxicityPediatric Cancer
Washington University School of Medicine 73
Not applicableLooking for participantsNCT05467111
What this trial is testing

Cardioprotective Effect of Acute Exercise in Breast Cancer Patients

Who this might be right for
Early-stage Breast Cancer
Technical University of Madrid 40
Not applicableStudy completedNCT03964142
What this trial is testing

Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity

Who this might be right for
CardiotoxicityCardiac Rehabilitation
Hospital Clinico Universitario de Santiago 122
Not applicableStudy completedNCT03553654
What this trial is testing

Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity

Who this might be right for
Neoplasms
University of California, San Diego 19
Not applicableUnknownNCT02471885
What this trial is testing

Effect of Remote Ischaemic Conditioning in Oncology Patients

Who this might be right for
Cardiotoxicity
University College, London 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370506
What this trial is testing

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Tanta University 36
Not applicableActive Not RecruitingNCT04892667
What this trial is testing

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Hodgkin
Assistance Publique - Hôpitaux de Paris 128
Not applicableEnded earlyNCT00679874
What this trial is testing

Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)

Who this might be right for
Breast Cancer
University of Calgary 66
Not applicableStudy completedNCT03940625
What this trial is testing

Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping

Who this might be right for
Breast CancerMyocardial DamageCardiotoxicity
Heinrich-Heine University, Duesseldorf 69
Large-scale testing (Phase 3)Looking for participantsNCT05271162
What this trial is testing

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

Who this might be right for
Cardiotoxicity
Maria Sklodowska-Curie National Research Institute of Oncology 220
Not applicableLooking for participantsNCT05703126
What this trial is testing

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Who this might be right for
Acute Myeloid Leukemia, AdultCardiotoxicityEndothelial Dysfunction
Samara State Medical University 100
Not applicableStudy completedNCT03166813
What this trial is testing

Remote Ischaemic Preconditioning in Childhood Cancer

Who this might be right for
Cardiotoxicity
The University of Hong Kong 68
Post-approval studies (Phase 4)Looking for participantsNCT06491680
What this trial is testing

Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer
Helwan University 40
Post-approval studies (Phase 4)UnknownNCT04939883
What this trial is testing

Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

Who this might be right for
Cancer
Hospital Sirio-Libanes 1,018
Testing effectiveness (Phase 2)Study completedNCT06888505
What this trial is testing

Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

Who this might be right for
Anthracyclines-Induced CardiotoxicityCardiotoxicity
Hawler Medical University 90
Not applicableLooking for participantsNCT05223413
What this trial is testing

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

Who this might be right for
Anthracycline-induced Cardiac ToxicityLymphoma
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 608
Large-scale testing (Phase 3)UnknownNCT02236806
What this trial is testing

Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab

Who this might be right for
Breast CancerCardiotoxicity
Azienda Ospedaliero-Universitaria Careggi 262
Large-scale testing (Phase 3)UnknownNCT04030546
What this trial is testing

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Who this might be right for
Patients With Cancer
Vilnius University 128
Post-approval studies (Phase 4)Study completedNCT02053974
What this trial is testing

Spironolactone Against Anthracycline-induced Cardiomyopathy

Who this might be right for
Anthracycline Induced Cardiotoxicity
TC Erciyes University 90
Not applicableStudy completedNCT01805778
What this trial is testing

Preventing Cardiac Sequelae in Pediatric Cancer Survivors

Who this might be right for
Anthracycline-induced Cardiotoxicity
The Hospital for Sick Children 1,128
Load More Results